A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
Clinical trial NCT06925113 · COMPLETED
Trial details
- NCT number
- NCT06925113
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-31
- Primary completion
- 2025-08-31
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.